ArticlePloS one2024

ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification.

Zhe Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.